Keyphrases
Transcatheter Aortic Valve Implantation
100%
Antithrombotic Therapy
100%
Dual Antiplatelet Therapy
71%
Aspirin
42%
Monotherapy
42%
Non-inferiority
28%
All-cause Mortality
14%
Severe Aortic Stenosis
14%
Japan
14%
Vulnerability
14%
Transfemoral Transcatheter Aortic Valve Implantation
14%
Perioperative Complications
14%
Bleeding
14%
Exclusion Criteria
14%
Patient's Will
14%
Bleeding Events
14%
Prospective Randomized Trial
14%
Event-based
14%
Multicenter Trial
14%
Balloon-expandable
14%
Bleeding Risk
14%
Myocardial Infarction
14%
Hemodialysis
14%
Valve Academic Research Consortium
14%
Peritoneal Dialysis
14%
High Bleeding Risk
14%
Self-expanding Valve
14%
Antithrombotic Drugs
14%
Oral Anticoagulant Therapy
14%
Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
Antithrombotic Therapy
100%
Antiplatelet
62%
Monotherapy
37%
Acetylsalicylic Acid
37%
Bleeding
25%
All Cause Mortality
12%
Aortic Stenosis
12%
Apoplexy
12%
Myocardial Infarction
12%
Peroperative Complication
12%
Anticoagulant Therapy
12%
Antithrombotic
12%
Hemodialysis
12%
Peritoneal Dialysis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antithrombotic Therapy
100%
Antiplatelet
71%
Acetylsalicylic Acid
42%
Monotherapy
42%
Bleeding
28%
All Cause Mortality
14%
Heart Infarction
14%
Aortic Stenosis
14%
Anticoagulant Agent
14%
Hemodialysis
14%
Anticoagulation Therapy
14%
Peroperative Complication
14%
Cerebrovascular Accident
14%